On October 8, Steve Barrett, Co-Chair of WilmerHale’s Technology Transactions and Licensing Practice Group, and George Shuster, Chair of WilmerHale’s Debt Finance Practice Group, led a discussion titled, "IP Monetization: Licensing and Finance Perspectives" during the Fierce Biotech Week Conference. The session shared insights into how various aspects of IP monetization transactions are best integrated to maximize economic value, while also maintaining a company’s widest possible freedom for additional technology and finance alternatives.

Fierce Biotech Week featured insights from C-suite and executive leadership at biotech, mid-sized and large pharma companies. Sessions centered on emerging trends and market dynamics that will help: effectively prioritize R&D spend; optimize drug development and clinical operations; mitigate the risks associated with capital raising; and unlock the potential of a joint venture, licensing or M&A deal. WilmerHale was a proud sponsor of the conference.